Status:
COMPLETED
Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85
Lead Sponsor:
The University of Queensland
Collaborating Sponsors:
Griffith University
The Prince Charles Hospital
Conditions:
Respiratory Viral Infection
Covid19
Eligibility:
All Genders
18-100 years
Phase:
PHASE3
Brief Summary
Parallel group, Wait-list design, with treatment delayed for 3 months. Participants will be randomized on a 1:1 ratio with 500 participants per group in Australia. Group 1: Wait-list control. One cap...
Detailed Description
The Covid-19 pandemic has been characterised by acute respiratory distress syndrome (ARDS) accompanied by a systemic cytokine-storm resulting in severe illness, respiratory failure and death in some. ...
Eligibility Criteria
Inclusion
- Participants who meet all of the following criteria are eligible for enrolment:
- HCW in front line clinical departments assessing or caring for patients with suspected or verified COV infection in one of the recruiting hospitals in Brisbane
- Participants who, in the opinion of the investigator, are able to comply with the protocol for its duration,
- Written informed consent signed and dated according to local regulations.
Exclusion
- Participants who meet any of these criteria are not eligible for enrolment:
- Staff with prior COV infection necessitating workforce removal
Key Trial Info
Start Date :
August 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04496245
Start Date
August 24 2020
End Date
September 30 2021
Last Update
March 9 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
The Prince Charles Hospital
Brisbane, Queensland, Australia, 4032
2
The Princess Alexandra Hospital
Brisbane, Queensland, Australia, 4102
3
Queensland Children's Hospital
South Brisbane, Queensland, Australia, 4101